tiprankstipranks
Kyverna Therapeutics, Inc. (KYTX)
NASDAQ:KYTX
US Market
KYTX
Kyverna Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see KYTX full AI Analyst Report?

Kyverna Therapeutics, Inc. (KYTX) Financial Statements

1,009 Followers

Kyverna Therapeutics, Inc. Financial Overview

Kyverna Therapeutics, Inc.'s market cap is currently $586.87M. The company's EPS TTM is $-0.8; its P/E ratio is -2.58; Kyverna Therapeutics, Inc. is scheduled to report earnings on March 26, 2026, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 7.03M$ 5.66M
Gross Profit$ -1.80M$ -2.13M$ -1.71M$ 7.03M$ 5.66M
Operating Income$ -169.83M$ -142.60M$ -62.41M$ -29.38M$ -26.35M
EBITDA$ -167.38M$ -125.20M$ -58.47M$ -27.78M$ -25.76M
Net Income$ -161.31M$ -127.48M$ -60.37M$ -28.89M$ -26.35M
Balance Sheet
Cash & Short-Term Investments$ 279.25M$ 285.98M$ 57.54M$ 51.32M$ 76.07M
Total Assets$ 293.83M$ 304.64M$ 75.19M$ 66.92M$ 85.49M
Total Debt$ 29.03M$ 8.24M$ 9.08M$ 10.56M$ 5.55M
Net Debt$ -95.06M$ -88.38M$ -25.57M$ -27.17M$ -70.51M
Total Liabilities$ 61.55M$ 38.06M$ 26.02M$ 20.25M$ 131.74M
Stockholders' Equity$ 232.28M$ 266.59M$ 49.18M$ 46.68M$ -46.25M
Cash Flow
Free Cash Flow$ -153.72M$ -116.45M$ -53.03M$ -36.88M$ -23.44M
Operating Cash Flow$ -153.71M$ -114.25M$ -52.41M$ -36.11M$ -22.16M
Investing Cash Flow$ 40.02M$ -160.90M$ -8.79M$ -14.10M$ -1.29M
Financing Cash Flow$ 141.17M$ 337.11M$ 58.12M$ 11.88M$ 72.52M
Currency in USD

Kyverna Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Kyverna Therapeutics, Inc. Debt to Assets

Balance Sheet >

Kyverna Therapeutics, Inc. Cash Flow

Cash Flow >

Kyverna Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >